Kokkola A - Search Results

1

Cohort profile: gastric cancer in the population-based, Finnish National Esophago-Gastric Cancer Cohort (FINEGO) Study.

Kauppila JH, Ohtonen P, Rantanen T, Tyrväinen T, Toikkanen V, Pääaho M, Valtola A, Räsänen J, Kallio R, Sihvo E, Saarnio J, Karttunen TJ, Pohjanen VM, Ristimäki A, Laine S, Kokkola A. Kauppila JH, et al. Among authors: kokkola a. BMJ Open. 2020 Oct 16;10(10):e039574. doi: 10.1136/bmjopen-2020-039574. BMJ Open. 2020. PMID: 33067296 Free PMC article.

2

High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.

Wiksten JP, Lundin J, Nordling S, Kokkola A, Stenman UH, Haglund C. Wiksten JP, et al. Among authors: kokkola a. Histopathology. 2005 Apr;46(4):380-8. doi: 10.1111/j.1365-2559.2005.02073.x. Histopathology. 2005. PMID: 15810949

3

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

Mrena J, Wiksten JP, Thiel A, Kokkola A, Pohjola L, Lundin J, Nordling S, Ristimäki A, Haglund C. Mrena J, et al. Among authors: kokkola a. Clin Cancer Res. 2005 Oct 15;11(20):7362-8. doi: 10.1158/1078-0432.CCR-05-0764. Clin Cancer Res. 2005. PMID: 16243808

4

Prognostic significance of cyclin A in gastric cancer.

Mrena J, Wiksten JP, Kokkola A, Nordling S, Haglund C, Ristimäki A. Mrena J, et al. Among authors: kokkola a. Int J Cancer. 2006 Oct 15;119(8):1897-901. doi: 10.1002/ijc.21944. Int J Cancer. 2006. PMID: 16708383 Free article.

5

MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.

Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimäki A, Haglund C. Mrena J, et al. Among authors: kokkola a. J Clin Pathol. 2006 Jun;59(6):618-23. doi: 10.1136/jcp.2005.033761. J Clin Pathol. 2006. PMID: 16731602 Free PMC article.

6

Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.

Linder N, Haglund C, Lundin M, Nordling S, Ristimäki A, Kokkola A, Mrena J, Wiksten JP, Lundin J. Linder N, et al. Among authors: kokkola a. J Clin Pathol. 2006 Sep;59(9):965-71. doi: 10.1136/jcp.2005.032524. J Clin Pathol. 2006. PMID: 16935971 Free PMC article.

7

Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.

Danielson H, Kokkola A, Kiviluoto T, Sirén J, Louhimo J, Kivilaakso E, Puolakkainen P. Danielson H, et al. Among authors: kokkola a. Scand J Surg. 2007;96(1):35-40. doi: 10.1177/145749690709600107. Scand J Surg. 2007. PMID: 17461310

8

15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.

Thiel A, Ganesan A, Mrena J, Junnila S, Nykänen A, Hemmes A, Tai HH, Monni O, Kokkola A, Haglund C, Petrova TV, Ristimäki A. Thiel A, et al. Among authors: kokkola a. Clin Cancer Res. 2009 Jul 15;15(14):4572-80. doi: 10.1158/1078-0432.CCR-08-2518. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584167

9

Early gastric cancer: clinical characteristics and results of surgery.

Nieminen A, Kokkola A, Ylä-Liedenpohja J, Louhimo J, Mustonen H, Puolakkainen P. Nieminen A, et al. Among authors: kokkola a. Dig Surg. 2009;26(5):378-83. doi: 10.1159/000226765. Epub 2009 Nov 13. Dig Surg. 2009. PMID: 19923825

10

COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.

Mrena J, Wiksten JP, Kokkola A, Nordling S, Ristimäki A, Haglund C. Mrena J, et al. Among authors: kokkola a. Tumour Biol. 2010 Jan;31(1):1-7. doi: 10.1007/s13277-009-0001-4. Epub 2009 Dec 18. Tumour Biol. 2010. PMID: 20237896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page